Analysts Review These Stocks Jan. 24th: TXN, KSU, AAPL, CATY, ALXN

Texas Instruments Inc. (NYSE:TXN): Oppenheimer believes that Texas Instruments reported “upbeat” Q4 results, and the firm raised its target on the stock to $40 from $37 while maintaining an Outperform rating.

Kansas City Southern (NYSE:KSU): Susquehanna raised its price target on Kansas City Southern following Q4 results. The firm cited management guidance, debt reduction program and possibility of a dividend initiation. Susquehanna expects the shares to take a break near term but believes it is still a buy for long-term investors. Shares are Positive rated.

Cathay General Bancorp (NASDAQ:CATY): RBC Capital increased its target on Cathay after the company reported higher than expected Q4 EPS. The firm maintains an Outperform rating on the stock.

Apple Inc. (NASDAQ:AAPL): Apple February call option implied volatility is at 34, March is at 30; compared to its 26-week average of 31 according to Track Data, suggesting larger near term price movement into the expected release of Q1 results today and the start of Macworld on January 26.

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN): After Alexion agreed to acquire Enobia, Oppenheimer sees a high probability that Enobia’s primary drug, an enzyme replacement therapy (ERT) for hypophosphatasia, will be approved in 2014. The firm estimates peak sales of $750M for the treatment, and maintains an Outperform rating on Alexion.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.